Topics

Lilly acquires Dermira for $1.1bn, expands dermatology portfolio

05:00 EST 15 Jan 2020 | BioPharma-Reporter

Eli Lilly set to acquire dermatological drugs developer, Dermira, in an $1.1bn all-cash deal, adding commercial and late-stage drugs to its portfolio.

Original Article: Lilly acquires Dermira for $1.1bn, expands dermatology portfolio

NEXT ARTICLE

More From BioPortfolio on "Lilly acquires Dermira for $1.1bn, expands dermatology portfolio"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...